Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection.
Watzka
Stefan B
SB
Division of Thoracic Surgery, Otto Wagner Hospital, Vienna, Austria. s.watzka@utanet.at
Rauscher-Pötsch
Irene
I
Stubenberger
Elisabeth
E
Getman
Vlad
V
Setinek
Ulrike
U
Tötsch
Martin
M
Pötschger
Ulrike
U
Müller
Michael R
MR
D000230:Adenocarcinoma / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D016896:Treatment Outcome; D000099200:Scaffold Protein ILK
D014408:Biomarkers, Tumor; D017346:Protein Serine-Threonine Kinases; D000099200:Scaffold Protein ILK